Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EnSite Velocity Cardiac Mapping System v5.2

K-Number: K172396 · 2018-04-23

ApplicantSt Jude Medical
Decision Date2018-04-23
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

EnSite Velocity Cardiac Mapping System v5.2 is a medical device manufactured by St Jude Medical. It received FDA 510(k) clearance on 2018-04-23 under approval number K172396. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EnSite Velocity Cardiac Mapping System v5.2?

EnSite Velocity Cardiac Mapping System v5.2 is a medical device that received FDA 510(k) clearance on 2018-04-23. It is manufactured by St Jude Medical. The 510(k) number is K172396.

When was EnSite Velocity Cardiac Mapping System v5.2 approved by the FDA?

EnSite Velocity Cardiac Mapping System v5.2 received FDA 510(k) clearance on 2018-04-23, under approval number K172396.

What company makes EnSite Velocity Cardiac Mapping System v5.2?

EnSite Velocity Cardiac Mapping System v5.2 is manufactured by St Jude Medical.

What is the FDA product code for EnSite Velocity Cardiac Mapping System v5.2?

The FDA product code for EnSite Velocity Cardiac Mapping System v5.2 is DQK.

Related Clinical Trials

NCT01254474 Evaluation of Depolarization and Repolarisation Activity During Cardiac Arrhythmia Using a Novel Monophasic Action Potential Catheter COMPLETED NCT07137455 EDEN Intracardiac Electrogram Recording and Classifying System ENROLLING_BY_INVITATION NCT03280862 DANISH-CRT - Does Electric Targeted LV Lead Positioning Improve Outcome in Patients With Heart Failure and Prolonged QRS COMPLETED NCT04097145 Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial RECRUITING NCT06170606 POLARx Post Approval Study (POLARx PAS) ACTIVE_NOT_RECRUITING NCT06510556 Feasibility Study of the FARAFLEX Mapping and PFA System RECRUITING

Related PubMed Literature

PMID: 40415770 Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory. REC, interventional cardiology (2024)

Other Devices by St Jude Medical

K160218AutoMark Module K160210EnSite Precision Cardiac Mapping System v2.0 K160335Advisor FL 15mm 12 Pole 333 Uni D, Advisor FL 20mm 12 Pole 555 Uni D, Advisor FL 15mm 12 Pole 333 Bi D, Advisor FL 20mm 12 Pole 555 Bi D K162643MediGuide Technology System K161873Pacel Flow Directed Pacing Catheter K160187Ensite Velocity Cardiac Mapping System v5.0, Ensite Automap Module v1.0

View all 13 devices →

Related Devices (Code: DQK)

K160218AutoMark ModuleSt Jude Medical K160210EnSite Precision Cardiac Mapping System v2.0St Jude Medical K162643MediGuide Technology SystemSt Jude Medical K162440CardioInsight Cardiac Mapping SystemCardioinsight Technologies, Inc. K160187Ensite Velocity Cardiac Mapping System v5.0, Ensite Automap Module v1.0St Jude Medical K160186EnSite Velocity Surface Electrode KitSt Jude Medical

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑